Analysis
Collegium Pharmaceuticals Strengthens ADHD Portfolio with AZSTARYS Acquisition
Collegium Pharmaceuticals enhances its ADHD lineup with the acquisition of AZSTARYS, signaling growth potential in the ADHD market.
Sarah Chen • May 12, 2026
Analysis
Dan Ives Predicts Bullish Future for Nasdaq: Insights into AI Rally
Dan Ives forecasts a bullish outlook for the Nasdaq, driven by a strong tech earnings season and AI advancements.
Catherine Walsh • May 11, 2026